Emotion regulation in emerging adults with major depressive disorder and frequent cannabis use

Nichols, Emily S.; Penner, Jacob; Ford, Kristen A.; Wammes, Michael; Neufeld, Richard W. J.; Mitchell, Derek; Greening, Steven G.; Théberge, Jean; Williamson, Peter C.; Osuch, Elizabeth A.

doi:10.1016/j.nicl.2021.102575

Cited by 5 publications

(2 citation statements)

References 86 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A baseline qualitative sample ( n = 62) was derived from the baseline quantitative sample based on the presence/absence of a chronic health condition; frequency of cannabis use (median = 25 hits per day, range 2–101 hits per day; 52.9% of the baseline qualitative sample reported 25 hits per day or less); and Emotion Regulation Questionnaire’s emotion suppression (median score = 3.25, range 1.24–6.25; 58.8% of the baseline qualitative sample scored 3.25 or less on emotion suppression subscale) and cognitive reappraisal (median score=4.83, range 1.67–7.00; 52.9% of the baseline qualitative sample scored 4.83 or less on cognitive reappraisal subscale) subscales scores (see ( Fedorova et al, 2020 ) for more details; ( Gross & John, 2003 ). Emotion regulation has been identified as an important construct in substance use research including cannabis use among young adults ( Nichols et al, 2021 ; Wong et al, 2013 ).…”

Section: Methodsmentioning

confidence: 99%

COVID-19’s Impact on Substance Use and Well-Being of Younger Adult Cannabis Users in California: A Mixed Methods Inquiry

Fedorova

Wong

Conn

et al. 2021

Journal of Drug Issues

View full text Add to dashboard Cite

Few qualitative studies have examined the impact of COVID-19 on cannabis and alcohol use, and overall well-being among cannabis users. Cannabis users (aged 26-32) were surveyed quantitatively (n=158) and interviewed qualitatively (n=29) in April 2020–May 2021 in Los Angeles. 63.3% of the quantitative sample reported increasing use of either cannabis (29.1%) or alcohol (15.2%) or both (19.0%) following the COVID-19 outbreak. Qualitative data revealed that increases in cannabis and alcohol use were largely attributed to changes in employment and staying at home resulting in fewer impediments and boredom. Themes of loneliness and utilization of various coping strategies were more pronounced among those who increased cannabis and/or alcohol use. For some, increases in cannabis/alcohol use were temporary until participants adjusted to “a new normal” or embraced more adaptive coping strategies. Results suggest monitoring cannabis/alcohol use trends and identifying coping strategies to reduce the pandemic’s impact on substance use and mental health.

show abstract

Section: Methodsmentioning

confidence: 99%

COVID-19’s Impact on Substance Use and Well-Being of Younger Adult Cannabis Users in California: A Mixed Methods Inquiry

Fedorova

Wong

Conn

et al. 2021

Journal of Drug Issues

View full text Add to dashboard Cite

show abstract

“…Five cross-sectional studies evaluated the effects of cannabis use in patients with MDD ( 40 , 51 , 79 , 81 , 88 ), with three identifying neural abnormalities compared to controls ( 40 , 51 , 79 ). Ford et al ( 51 ) employed a passive music listening paradigm to investigate variations in reward processing in brain activity across four groups of youth: healthy controls, frequent cannabis users, individuals with MDD, and individuals with MDD who use cannabis.…”

Section: Resultsmentioning

confidence: 99%

Cannabis use and mood disorders: a systematic review

Sorkhou,

Dent,

George

2024

Front. Public Health

View full text Add to dashboard Cite

BackgroundProblematic cannabis use is highly prevalent among people with mood disorders. This underscores the need to understand the effects of cannabis and cannabinoids in this population, especially considering legalization of recreational cannabis use.ObjectivesWe aimed to (1) systematically evaluate cross-sectional and longitudinal studies investigating the interplay between cannabis use, cannabis use disorder (CUD), and the occurrence of mood disorders and symptoms, with a focus on major depressive disorder (MDD) and bipolar disorder (BD) and; (2) examine the effects of cannabis on the prognosis and treatment outcomes of MDD and BD.MethodsFollowing PRISMA guidelines, we conducted an extensive search for English-language studies investigating the potential impact of cannabis on the development and prognosis of mood disorders published from inception through November 2023, using EMBASE, PsycINFO, PubMed, and MEDLINE databases.ResultsOur literature search identified 3,262 studies, with 78 meeting inclusion criteria. We found that cannabis use is associated with increased depressive and manic symptoms in the general population in addition to an elevated likelihood of developing MDD and BD. Furthermore, we observed that cannabis use is linked to an unfavorable prognosis in both MDD or BD.DiscussionOur findings suggest that cannabis use may negatively influence the development, course, and prognosis of MDD and BD. Future well-designed studies, considering type, amount, and frequency of cannabis use while addressing confounding factors, are imperative for a comprehensive understanding of this relationship.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023481634.

show abstract

Altered regional brain activity moderating the relationship between childhood trauma and depression severity

Luo,

Li,

Zhang

et al. 2024

Journal of Affective Disorders

View full text Add to dashboard Cite

Emotion regulation in emerging adults with major depressive disorder and frequent cannabis use

Cited by 5 publications

References 86 publications

COVID-19’s Impact on Substance Use and Well-Being of Younger Adult Cannabis Users in California: A Mixed Methods Inquiry

COVID-19’s Impact on Substance Use and Well-Being of Younger Adult Cannabis Users in California: A Mixed Methods Inquiry

Cannabis use and mood disorders: a systematic review

Altered regional brain activity moderating the relationship between childhood trauma and depression severity

Contact Info

Product

Resources

About